Key facts
- This page summarizes David Soane's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2022, 10:32.
David Soane - 08 Nov 2022 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 08 Nov 2022
- Net transaction value
- +$4,148
- SEC form
- 4
- Accepted by SEC
- 09 Nov 2022, 10:32:51 UTC
- Prior SEC filing
- 28 Oct 2022
- Next SEC filing
- 06 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- David S. Soane (individually)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Soane filed Form 4 for Comera Life Sciences Holdings, Inc. on 09 Nov 2022.
Change
- Previous filing in this sequence was filed on 28 Oct 2022.
- Current net transaction value: +$4,148.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMRA
transaction
Common Stock
Purchase
- Transaction value
- $4,148
- Shares
- +3,000
- Change %
- +0.09%
- Price
- $1.38
- Shares after
- 3,268,995
- Date
- 08 Nov 2022
- Ownership
- by Trust
- Footnotes
- F1, F2, F3
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 589,786
- Date
- 08 Nov 2022
- Ownership
- Direct
- Footnotes
- F4
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,162
- Date
- 08 Nov 2022
- Ownership
- by Trust
- Footnotes
- F5, F6
CMRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,162
- Date
- 08 Nov 2022
- Ownership
- by Trust
- Footnotes
- F5, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.36 to $1.43, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Footnote F2
Includes 663,288 Earn-Out Shares. Earn-Out Shares are shares of Common Stock held in escrow, which shares will be released if, at any time prior to May 19, 2024, either (i) the volume-weighted average price of the Common Stock is equal to or greater than $12.50 for twenty trading days within a thirty trading day period or (ii) upon a change of control with aggregate consideration in excess of $12.50 per share of Common Stock.
Footnote F3
Held by The Soane Family Trust, of which David Soane is a trustee and members of the Dr. Soane's immediate family are trustees and beneficiaries. Dr. Soane disclaims beneficial ownership except to the extent of his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
Footnote F4
Includes 119,779 Earn-Out Shares
Footnote F5
Includes 4,298 Earn-Out Shares
Footnote F6
Held by the Alexander V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes
Footnote F7
Held by the Nicholas V. Soane 2019 Irrevocable Trust. Members of David Soane's immediate family serve as trustee and are beneficiaries of such trusts. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purposes